ESMO 2024: Risk for Recurrence High for HR-Positive/HER2-Negative High-Risk Node-Negative Early Breast Cancer
Patients with high-risk node-negative disease had 3.2 times higher risk for distant recurrence compared with the overall node-negative population
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.